GPR75
Basic information
Region (hg38): 2:53852911-53859967
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GPR75 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 38 | 42 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 6 | |||||
Total | 0 | 0 | 44 | 4 | 5 |
Variants in GPR75
This is a list of pathogenic ClinVar variants found in the GPR75 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-53853139-C-T | not specified | Uncertain significance (Dec 08, 2023) | ||
2-53853142-A-G | not specified | Uncertain significance (Jan 10, 2023) | ||
2-53853300-T-C | not specified | Uncertain significance (May 11, 2022) | ||
2-53853322-T-G | not specified | Uncertain significance (Jul 05, 2023) | ||
2-53853324-C-T | not specified | Uncertain significance (Jan 19, 2024) | ||
2-53853330-T-C | not specified | Uncertain significance (Feb 23, 2023) | ||
2-53853352-G-C | not specified | Uncertain significance (Nov 09, 2023) | ||
2-53853358-A-T | not specified | Uncertain significance (Oct 13, 2023) | ||
2-53853387-C-T | not specified | Uncertain significance (Sep 29, 2023) | ||
2-53853403-T-C | not specified | Uncertain significance (Apr 24, 2024) | ||
2-53853435-A-G | not specified | Uncertain significance (Apr 10, 2023) | ||
2-53853466-A-C | not specified | Uncertain significance (Mar 21, 2023) | ||
2-53853492-G-T | not specified | Uncertain significance (Nov 30, 2022) | ||
2-53853534-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
2-53853543-G-C | not specified | Uncertain significance (Aug 12, 2021) | ||
2-53853558-C-T | not specified | Uncertain significance (Mar 21, 2024) | ||
2-53853663-A-G | not specified | Uncertain significance (Aug 01, 2022) | ||
2-53853664-T-C | not specified | Uncertain significance (Aug 14, 2023) | ||
2-53853713-G-T | GPR75-related disorder | Benign (May 28, 2019) | ||
2-53853756-C-A | not specified | Uncertain significance (Feb 27, 2024) | ||
2-53853756-C-T | not specified | Uncertain significance (Oct 17, 2023) | ||
2-53853780-A-G | not specified | Uncertain significance (Sep 20, 2023) | ||
2-53853845-C-A | not specified | Uncertain significance (May 23, 2024) | ||
2-53853852-C-T | not specified | Uncertain significance (Dec 08, 2023) | ||
2-53853900-C-T | GPR75-related disorder | Benign (Jun 07, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GPR75 | protein_coding | protein_coding | ENST00000394705 | 1 | 7077 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000158 | 0.675 | 125702 | 0 | 46 | 125748 | 0.000183 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0359 | 292 | 290 | 1.01 | 0.0000155 | 3540 |
Missense in Polyphen | 87 | 113.31 | 0.76779 | 1397 | ||
Synonymous | -1.62 | 141 | 119 | 1.19 | 0.00000665 | 1125 |
Loss of Function | 0.969 | 9 | 12.7 | 0.707 | 7.80e-7 | 159 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000420 | 0.000420 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000217 | 0.000217 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000176 | 0.000176 |
Middle Eastern | 0.000217 | 0.000217 |
South Asian | 0.000261 | 0.000261 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: G protein-coupled receptor that is activated by the chemokine CCL5/RANTES. Probably coupled to heterotrimeric Gq proteins, it stimulates inositol trisphosphate production and calcium mobilization upon activation. Together with CCL5/RANTES, may play a role in neuron survival through activation of a downstream signaling pathway involving the PI3, Akt and MAP kinases. CCL5/RANTES may also regulate insulin secretion by pancreatic islet cells through activation of this receptor. {ECO:0000250|UniProtKB:Q6X632, ECO:0000303|PubMed:23979485}.;
- Pathway
- GPCRs, Class A Rhodopsin-like
(Consensus)
Recessive Scores
- pRec
- 0.108
Intolerance Scores
- loftool
- 0.686
- rvis_EVS
- -0.35
- rvis_percentile_EVS
- 29.43
Haploinsufficiency Scores
- pHI
- 0.253
- hipred
- N
- hipred_score
- 0.350
- ghis
- 0.539
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.192
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gpr75
- Phenotype
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;chemokine-mediated signaling pathway;regulation of neuron death
- Cellular component
- integral component of plasma membrane
- Molecular function
- G protein-coupled receptor activity;C-C chemokine receptor activity